The short answer: The GI-MAP is a stool test that uses qPCR, a quantitative DNA technology, to measure what is living in your gut: pathogens, H. pylori, beneficial bacteria, opportunistic overgrowth, and yeast, along with markers of digestion, inflammation, and immune function. It takes one sample, collected at home. It can point toward why your gut is off, but it is not a diagnosis, and the results only mean something when a clinician reads them against your actual symptoms.
We order a lot of GI-MAP panels at Aspire, and we spend nearly as much time explaining what this test cannot do as what it can. This post covers both sides. If you read our DUTCH test explainer, this follows the same format.
How the test works
The GI-MAP (Gastrointestinal Microbial Assay Plus) is run by Diagnostic Solutions Laboratory. Instead of trying to grow organisms in a culture dish, the lab looks for their DNA using quantitative PCR. That matters for two reasons. Some gut organisms grow poorly in culture and get missed. And qPCR gives a number, so instead of a plain positive or negative you see how much of an organism is present compared to a reference range.
Collection is one stool sample, done at home with the kit's tray and vial, then shipped to the lab in a prepaid box. Results usually come back about one to two weeks after the lab receives the sample.
At Aspire, testing starts with a conversation. You meet with one of our nurse practitioners by telemedicine (we see patients across Minnesota, with offices in Golden Valley and Independence), we go through your history, and we decide together whether the GI-MAP is the right panel or whether a different test, or none, makes more sense. A stool panel ordered without that context tends to produce anxiety instead of answers.
What does the GI-MAP test detect?
The report groups results into sections. Here is what each covers.
Pathogens
The first section screens for organisms that cause acute GI illness: C. difficile toxins A and B, Campylobacter, Salmonella, Giardia, Cryptosporidium, and norovirus, among others. A detection here does not automatically mean active infection, because DNA can linger after your immune system has already cleared the bug. Your symptoms decide whether a finding matters.
H. pylori and its virulence factors
H. pylori is the stomach bacterium linked to ulcers and gastritis. A large share of people carry it and never have a problem, which is why the GI-MAP reports two things: how much is present, and whether virulence factors like CagA and VacA are detected. Those genes mark strains more likely to cause damage. High levels plus virulence factors plus upper-GI symptoms is a very different conversation than a low-level detection in someone who feels fine.
The beneficial bacteria
This is the section most standard stool tests skip entirely. The GI-MAP quantifies keystone species like Akkermansia muciniphila, which maintains the mucus layer of your gut lining, and Faecalibacterium prausnitzii, a major producer of butyrate, the fuel your colon cells run on. It also measures Bifidobacterium and Lactobacillus. We pay close attention here with patients whose gut never recovered after a round of antibiotics, because depleted keystone species are a common thread in that story.
Opportunistic overgrowth and yeast
Organisms like Klebsiella, Citrobacter, Proteus, Staphylococcus, and Streptococcus live in many healthy guts at low levels. Trouble starts when they overgrow into space the beneficial bacteria used to hold. The panel also measures Candida albicans and Methanobacteriaceae, a family of methane producers that shows up often in patients with slow motility and stubborn constipation.
The digestion and immune markers
The last section is about how your gut is functioning, separate from who lives there:
- Calprotectin: an inflammation marker, and the one on this panel that conventional gastroenterology also uses. A significantly elevated calprotectin moves the conversation toward GI referral and colonoscopy, full stop. MedlinePlus has a plain overview of calprotectin testing.
- Pancreatic elastase-1: reflects digestive enzyme output from your pancreas.
- Steatocrit: fat in the stool, a sign you are not absorbing what you eat.
- Secretory IgA: the antibody your gut lining uses as a first line of defense. Both low and high values tell us something.
- Zonulin: an add-on marker tied to intestinal permeability. It is the most contested number on the report, and we treat it as a supporting detail, never a headline.
It also flags beta-glucuronidase, tied to estrogen recycling, and occult blood.
Who the test is for
The patients we most often order a GI-MAP for fall into a few groups: people with months of bloating, loose stools, or constipation whose standard workup came back normal; people whose gut has not been right since a course of antibiotics or a bout of food poisoning; and people with symptoms that do not look digestive at first, like stubborn skin issues or fatigue, where the history keeps circling back to the gut. Our testing page puts it this way: digestive issues, and more than a few non-digestive ones. Fatigue in particular has several possible drivers; we wrote about one of them in our post on mold exposure and chronic fatigue.
When we would talk you out of it
This part matters more than the marketing. There are situations where the GI-MAP is the wrong first move:
- Red-flag symptoms. Blood in your stool, unintended weight loss, iron-deficiency anemia, fevers, or GI pain that wakes you at night belong with gastroenterology first. A functional stool panel should never delay a colonoscopy. If that is your picture, we will say so and help you get the referral.
- You want a diagnosis. The GI-MAP does not diagnose IBS, Crohn's disease, ulcerative colitis, or celiac disease. It adds information around those questions; it does not answer them.
- You suspect SIBO. Small intestinal bacterial overgrowth is assessed with a breath test. A stool panel samples the far end of the system and cannot confirm or rule out SIBO.
- You would not act on the results. If nothing on the report would change what you eat, take, or do, save the money.
The honest part: what skeptics say
Most conventional GI physicians do not order the GI-MAP, and their reasons deserve a straight answer. DNA testing can detect organisms from an infection your body already cleared. Healthy guts carry low levels of "bad" organisms, so detection is not the same thing as disease. The reference ranges are proprietary to the lab rather than drawn from large independent population studies. And in the wrong hands, a page of flagged markers becomes a shopping cart of supplements with no plan behind it.
We think those criticisms are fair, and they shape how we use the test. We read patterns across the whole report next to your history rather than reacting to single flagged lines. When a result would change management in a serious way, a C. difficile detection or a high calprotectin for example, we confirm it through conventional testing before anyone gets treated. The GI-MAP is a map. It is only as useful as the clinician reading it.
What happens after your results
Results come back to us, and we schedule a follow-up to walk through the report marker by marker in plain English. From there, the plan lands in one of three places: treat what we found, retest in a few months to watch a trend, or refer you to a specialist when the findings call for one. When supplements are part of the plan, we keep the list short and specific, ordered through our Fullscript dispensary, and most plans lean at least as hard on food, fiber, sleep, and stress as they do on anything in a bottle.
Frequently asked questions
How do you collect the GI-MAP sample?
One sample, at home. The kit includes a collection tray, a vial with a small scoop, and a prepaid shipping box. We go over the instructions at your consult.
How long do results take?
Plan on about one to two weeks after the lab receives your sample. We schedule your review visit as soon as the report lands.
Is the GI-MAP covered by insurance?
Functional panels like this one are generally cash-pay. Some patients use HSA or FSA funds; check with your plan administrator. We tell you the exact cost before anything is ordered.
Can the GI-MAP diagnose IBS or SIBO?
No. IBS is a clinical diagnosis made from your symptoms and history, and SIBO requires a breath test. The GI-MAP can add useful context to both conversations, and that is the honest ceiling of what it does.